Arrowhead Pharmaceuticals is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. The company has eight products in its pipeline, in various stages of development. In 2015, the company substantially expanded its intellectual property holdings through complete acquisition of the full RNAi research and development portfolio, and assets from Novartis. More information...
According to PR-model, arrowheadpharma.com is ranked 2,092,727th in multilingual Wikipedia, in particular this website is ranked 1,153,957th in English Wikipedia.
The website is placed before safespot-eu.org and after siblingrivalrypress.com in the BestRef global ranking of the most important sources of Wikipedia.
